KALMAR CORPORATION, MANAGERS' TRANSACTIONS, 5 MAY 2025 AT 1:30 PM (EEST) Kalmar Corporation - Managers' transactions - Torttila-Miettinen____________________________________________ Person subject to the notification requirementName: Torttila-Miettinen, EmiliaPosition: Member of the Board/Deputy memberIssuer: Kalmar CorporationLEI: 636700Z25ZQXLMZ3CY73 Notification type: INITIAL NOTIFICATIONReference number: 636700Z25ZQXLMZ3CY73_20250502083903_17____________________________________________ Transaction date: ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ:FTAI) (the “Company”) today announced that Joe Adams, Chief Executive Officer, will present at the Barclays Americas Select Franchise Conference 2025 at 10:15AM (ET) on Tuesday, May 6, 2025 in London. As part of his presentation, Mr. Adams will discuss, among other items, the information in the below: A detailed walkthrough of FTAI’s outlook on Adjusted Free Cashflow for 2025.Expected uses of proceeds for excess cashflows generated throug ...

KALMAR CORPORATION, MANAGERS' TRANSACTIONS, 5 MAY 2025 AT 1:30 PM (EEST) Kalmar Corporation - Managers' transactions - Pohjonen____________________________________________ Person subject to the notification requirementName: Pohjonen, SariPosition: Member of the Board/Deputy memberIssuer: Kalmar CorporationLEI: 636700Z25ZQXLMZ3CY73 Notification type: INITIAL NOTIFICATIONReference number: 636700Z25ZQXLMZ3CY73_20250502083903_16____________________________________________ Transaction date: 2025-04-30Venue: XHEL ...

VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) announces with tremendous sadness the passing of our fellow director and colleague, Graham Wheelock. Graham served on K92’s Board of Directors continuously from February 2016, having been appointed to the Board of K92 when the Company first began trading in 2016. Graham’s extensive mining career as a geologist and mining professional spanned over 40 years working for international ...

Company Highlights Strategic Transition to Artificial Intelligence Data Centers and Reports Growth in Certain Business UnitsLAS VEGAS, May 05, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced preliminary financial results for the first quarter of 2025, which ended March 31, 2025, with revenue surpassing $25 million. The Company also issued guidance for the full fiscal year 2025, projecting revenue betwee ...

Delivers Approximately 18% Net Sales GrowthStrong Operating Performance on Input, Quality and Logistics CostsUpdates 2025 Outlook BEDMINSTER, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Compared to Prior Year Period Net sales of $263.2 million, an increase of 17.6%.Net loss of $12.7 million, compared to the prior year period net income of ...

PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2025. First Quarter 2025 Highlights First quarter revenues of $382.7 million increased 3.7% on a reported basis and decreased 3.5% on an organic basis compared to the prior year. First quarter GAAP earnings per diluted share of $(0.33), compared to $(0.04) in the prior year; adjusted ea ...

In 2019, Elanco exclusively licensed lotilaner to Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) for exploration as a solution to several unmet human health needs. In 2023, XDEMVY became the first lotilaner- based product approved for human use and the only FDA-approved medicine for treatment of Demodex blepharitis (DB), a common eyelid disease in humans caused by Demodex mites. "Elanco's team of scientific experts is focused on identifying and developing molecules to generate high-impact innovation, not just ...

Company to use facility to further development of RetinalGenix’s therapies for neurodegenerative and retinal diseasesAPOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life science incubator MBC BioLabs for a brand new facility located in San Carlos, California. The lease includes an option for Mission BioCapital, an affiliate of MBC Biolabs, to potentially invest in Retina ...

Core Insights - Atos has launched the SecureHorizons NIS2 Compliance Manager Application, powered by ServiceNow, to automate compliance processes for organizations facing the NIS2 Directive [1][4] - The NIS2 Directive aims to enhance cybersecurity across the EU, making compliance mandatory for all companies operating within or trading in the EU [2][3] Company Overview - Atos is a global leader in digital transformation with approximately 74,000 employees and annual revenue of around €10 billion [8] - The company specializes in cybersecurity, cloud services, and high-performance computing, providing tailored solutions across 68 countries [8] Product Features - The SecureHorizons application replaces manual processes with automated workflows, offering a unified dashboard for compliance monitoring [4][7] - It integrates people, processes, and technology to streamline compliance efforts and reduce enterprise risk [7] - The application is designed to help organizations proactively address compliance gaps and respond to audit requirements [5][6]